$2.060
-0.086 (-4.19%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ACRV Prediction & Forecast by Similar Chart Analysis
Alphio's ACRV stock price prediction model matches the current Acrivon Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.09 (+1.34%). The 1-week path is $1.89 (-8.42%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Acrivon Therapeutics, Inc. Stock?
Acrivon Therapeutics Inc is a good buy right now due to its potential upside indicated by an analyst price target of $8, which represents a significant upside from the current price of $2.06. Additionally, the stock has shown a strong 1-year change of +53.73%, suggesting positive momentum over the longer term. The main risk is the ongoing losses, with a net income of -$19,064,000 reported for Q2 2026, which highlights profitability challenges that investors should monitor closely.
ACRV stock price ended at $2.06 on Friday, after losing -4.19%
Acrivon Therapeutics, Inc. (ACRV) last closed at $2.06, losing -4.19%. These facts feed the 1-day and 1-week ACRV price prediction above.
Forecast Drivers
Acrivon Therapeutics, Inc. (ACRV) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches ACRV, ranked by similarity.
Seasonality analysis for ACRV
Historically the probability of a positive August return for ACRV is 34.38%. November offers the highest probability of a positive month at 51.28%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ACRV
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $0.98 | $1.20 | $1.26 | -41.51% |
| Sep 2026 | $1.31 | $1.33 | $1.55 | -35.20% |
| Oct 2026 | $1.11 | $1.37 | $1.58 | -33.66% |
| Nov 2026 | $1.48 | $1.55 | $1.73 | -24.87% |
| Dec 2026 | $1.21 | $1.27 | $1.53 | -38.50% |
In 2026, Acrivon Therapeutics, Inc. (ACRV) is projected to range from $0.98 to $1.73.
Acrivon Therapeutics, Inc. 2026 monthly forecast
In Aug 2026, Acrivon Therapeutics, Inc. is projected to average $1.20, with a low of $0.98 and high of $1.26.
In Sep 2026, Acrivon Therapeutics, Inc. is projected to average $1.33, with a low of $1.31 and high of $1.55.
In Oct 2026, Acrivon Therapeutics, Inc. is projected to average $1.37, with a low of $1.11 and high of $1.58.
In Nov 2026, Acrivon Therapeutics, Inc. is projected to average $1.55, with a low of $1.48 and high of $1.73.
In Dec 2026, Acrivon Therapeutics, Inc. is projected to average $1.27, with a low of $1.21 and high of $1.53.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.